Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

MLA

Mark S Pearson, PhD, et al. “Immunomics-Guided Discovery of Serum and Urine Antibodies for Diagnosing Urogenital Schistosomiasis: A Biomarker Identification Study.” The Lancet Microbe, vol. 2, no. 11, Nov. 2021, pp. e617–26. EBSCOhost, https://doi.org/10.1016/S2666-5247(21)00150-6.

APA

Mark S Pearson, P., Bemnet A Tedla, P., Gebeyaw G Mekonnen, P., Carla Proietti, P., Luke Becker, Bs., Rie Nakajima, Ms., Al Jasinskas, P., Denise L Doolan, P., Abena S Amoah, P., Stefanie Knopp, P., David Rollinson, P., Said M Ali, Ms., Fatma Kabole, M., Cornelis H Hokke, P., Akim A Adegnika, M., Matt A Field, P., Govert van Dam, P., Paul L A M Corstjens, P., Takafira Mduluza, P., … Alex Loukas, P. (2021). Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study. The Lancet Microbe, 2(11), e617–e626. https://doi.org/10.1016/S2666-5247(21)00150-6

Chicago

Mark S Pearson, PhD, PhD Bemnet A Tedla, PhD Gebeyaw G Mekonnen, PhD Carla Proietti, Bsc Luke Becker, Msc Rie Nakajima, PhD Al Jasinskas, et al. 2021. “Immunomics-Guided Discovery of Serum and Urine Antibodies for Diagnosing Urogenital Schistosomiasis: A Biomarker Identification Study.” The Lancet Microbe 2 (11): e617–26. doi:10.1016/S2666-5247(21)00150-6.